FLGC vs. MGX, IFRX, KRON, OTLK, OSTX, CRVO, AVTX, IPA, RENB, and KLRS
Should you be buying Flora Growth stock or one of its competitors? The main competitors of Flora Growth include Metagenomi (MGX), InflaRx (IFRX), Kronos Bio (KRON), Oncobiologics (OTLK), OS Therapies (OSTX), CervoMed (CRVO), Avalo Therapeutics (AVTX), ImmunoPrecise Antibodies (IPA), Renovaro (RENB), and Kalaris Therapeutics (KLRS). These companies are all part of the "pharmaceutical products" industry.
Flora Growth vs. Its Competitors
Metagenomi (NASDAQ:MGX) and Flora Growth (NASDAQ:FLGC) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, media sentiment, risk, analyst recommendations, earnings, institutional ownership, valuation and dividends.
Metagenomi currently has a consensus target price of $13.00, suggesting a potential upside of 580.63%. Flora Growth has a consensus target price of $4.00, suggesting a potential upside of 555.63%. Given Metagenomi's stronger consensus rating and higher possible upside, analysts clearly believe Metagenomi is more favorable than Flora Growth.
Metagenomi has a beta of -0.38, indicating that its stock price is 138% less volatile than the S&P 500. Comparatively, Flora Growth has a beta of 1.97, indicating that its stock price is 97% more volatile than the S&P 500.
Flora Growth has a net margin of -24.85% compared to Metagenomi's net margin of -172.21%. Metagenomi's return on equity of -31.21% beat Flora Growth's return on equity.
Flora Growth has higher revenue and earnings than Metagenomi. Metagenomi is trading at a lower price-to-earnings ratio than Flora Growth, indicating that it is currently the more affordable of the two stocks.
In the previous week, Flora Growth had 2 more articles in the media than Metagenomi. MarketBeat recorded 2 mentions for Flora Growth and 0 mentions for Metagenomi. Flora Growth's average media sentiment score of 0.79 beat Metagenomi's score of 0.00 indicating that Flora Growth is being referred to more favorably in the news media.
36.0% of Flora Growth shares are held by institutional investors. 17.8% of Metagenomi shares are held by company insiders. Comparatively, 12.6% of Flora Growth shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Summary
Flora Growth beats Metagenomi on 9 of the 16 factors compared between the two stocks.
Get Flora Growth News Delivered to You Automatically
Sign up to receive the latest news and ratings for FLGC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding FLGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Flora Growth Competitors List
Related Companies and Tools
This page (NASDAQ:FLGC) was last updated on 7/9/2025 by MarketBeat.com Staff
